Acadia Pharmaceuticals buy Needham & Company LLC
Start price
09.04.24
/
50%
€16.56
Target price
09.04.25
€29.40
Performance (%)
-18.09%
Price
08:32
€13.83
Summary
This prediction is currently active. The price of Acadia Pharmaceuticals has decreased since the start of the prediction. Compared to the start price this results in a performance of -18.09%. This prediction currently runs until 09.04.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Acadia Pharmaceuticals | -3.956% | -3.956% |
iShares Core DAX® | -0.383% | 5.404% |
iShares Nasdaq 100 | 1.248% | 6.732% |
iShares Nikkei 225® | 0.525% | 1.840% |
iShares S&P 500 | 0.640% | 4.710% |
Comments by Needham___Company_LL for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $32.00 price target on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Needham___Company_LL for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€15.02
09.05.24
09.05.24
€27.88
09.05.25
09.05.25
-6.73%
08:32
08:32
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€18.20
12.03.24
12.03.24
€29.32
12.03.25
12.03.25
-22.53%
08:32
08:32
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€21.60
28.02.24
28.02.24
€33.24
28.02.25
28.02.25
-34.72%
08:32
08:32
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€24.80
24.01.24
24.01.24
€33.86
24.01.25
24.01.25
-45.32%
08:32
08:32